Carcinosin (Deseret Biologicals, Inc.)
Welcome to the PulseAid listing for the Carcinosin drug offered from Deseret Biologicals, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Deseret Biologicals, Inc. |
NON-PROPRIETARY NAME: | Carcinosin |
SUBSTANCE NAME: | HUMAN BREAST TUMOR CELL |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | LIQUID |
MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
START MARKETING DATE: | 2012-10-08 |
END MARKETING DATE: | 2020-09-02 |
Carcinosin HUMAN OTC DRUG Details:
Item Description | Carcinosin from Deseret Biologicals, Inc. |
LABELER NAME: | Deseret Biologicals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 30([hp_C]/mL) |
START MARKETING DATE: | 2012-10-08 |
END MARKETING DATE: | 2020-09-02 |
PRODUCT ID: | 43742-0208_d6814660-ae4e-4885-99bb-b929a93b7a5e |
PRODUCT NDC: | 43742-0208 |
APPLICATION NUMBER: | |
Other HUMAN BREAST TUMOR CELL Pharmaceutical Manufacturers / Labelers: